LLY

928.56

+2.46%↑

JNJ

186.29

-0.27%↓

UNH

327.86

-0.81%↓

NVS

125.19

+0.06%↑

ABT

124.68

-0.87%↓

LLY

928.56

+2.46%↑

JNJ

186.29

-0.27%↓

UNH

327.86

-0.81%↓

NVS

125.19

+0.06%↑

ABT

124.68

-0.87%↓

LLY

928.56

+2.46%↑

JNJ

186.29

-0.27%↓

UNH

327.86

-0.81%↓

NVS

125.19

+0.06%↑

ABT

124.68

-0.87%↓

LLY

928.56

+2.46%↑

JNJ

186.29

-0.27%↓

UNH

327.86

-0.81%↓

NVS

125.19

+0.06%↑

ABT

124.68

-0.87%↓

LLY

928.56

+2.46%↑

JNJ

186.29

-0.27%↓

UNH

327.86

-0.81%↓

NVS

125.19

+0.06%↑

ABT

124.68

-0.87%↓

Home・Akcijų sąrašas・Celldex Therapeutics Inc

Celldex Therapeutics Inc

Uždarymo kaina

SektoriusSveikatos priežiūra

23.64 -0.71

Pirkti Parduoti

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

23.15

Max

23.97

Pagrindiniai rodikliai
By Trading Economics
Pajamos	-2.8M -57M
Pardavimai	35K 730K
Pelno marža	-7,753.425
Darbuotojai	186
EBITDA	-1.1M -63M

Rekomendacijos
By TipRanks
Rekomendacijos	Stiprus pirkimas
12 mėnesių prognozė	+106.29% upside

Dividendai
By Dow Jones
Kitas uždarbis	2025-11-11

Rinkos statistika
By TradingEconomics
Rinkos kapitalizacija	196M 1.6B
Ankstesnė atidarymo kaina	24.35
Ankstesnė uždarymo kaina	23.64

Naujienos nuotaikos

By Acuity

100%

355 / 374 reitingas Healthcare

Techninis įvertinimas

By Trading Central

Pasitikėjimas

Weak Bullish Evidence

18.91 / 20.63 Palaikymas ir pasipriešinimas

Celldex Therapeutics Inc Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2025-11-05 23:51; UTC

Uždarbis

CoreCivic Cuts Fiscal Year Guidance Amid Efforts to Launch New Detention Facilities

2025-11-05 23:10; UTC

Uždarbis

DBS Third Quarter Net Dips 2.0%

2025-11-05 22:55; UTC

Uždarbis

Arm Holdings 2Q Profit Climbs on Record Demand

2025-11-05 22:23; UTC

Uždarbis

NAB's Annual Profit Falls 2.9% Amid Higher Costs, Credit Impairments -- Update

2025-11-05 23:52; UTC

Uždarbis

United Overseas Bank 3Q Net Interest Income S$2.265B Vs. $2.46B >U11.SG

2025-11-05 23:49; UTC

Uždarbis

United Overseas Bank 3Q Total Income S$3.40B Vs. S$3.83B >U11.SG

2025-11-05 23:49; UTC

Uždarbis

United Overseas Bank 3Q Net S$443M Vs. Net S$1.61B >U11.SG

2025-11-05 23:45; UTC

Rinkos pokalbiai

Nikkei May Rise on Weaker Yen, U.S. Tech Rebound -- Market Talk

2025-11-05 23:42; UTC

Rinkos pokalbiai

Gold Edges Lower Amid Reduced Odds of Fed Rate-Cut -- Market Talk

2025-11-05 23:12; UTC

Uždarbis

Nutrien 3Q Adj EPS 97c >NTR.T

2025-11-05 23:11; UTC

Uždarbis

Nutrien: Initiating Review of Strategic Alternatives for Phosphate Business >NTR.T

2025-11-05 23:10; UTC

Uždarbis

Nutrien 3Q Sales $6.01B >NTR.T

2025-11-05 23:10; UTC

Rinkos pokalbiai

Uždarbis

AppLovin Says Conversion Rate Is Biggest Growth Lever -- Market Talk

2025-11-05 23:10; UTC

Uždarbis

Nutrien 3Q EPS 96c >NTR.T

2025-11-05 23:04; UTC

Uždarbis

Qualcomm Stock Slides After Earnings Beat -- Barrons.com

2025-11-05 23:03; UTC

Rinkos pokalbiai

Macklem: Canada's Regulatory Overlap Turns Off Foreign Investors -- Market Talk

2025-11-05 22:55; UTC

Rinkos pokalbiai

Macklem Says Inflation and Productivity Are Intertwined -- Market Talk

2025-11-05 22:55; UTC

Uždarbis

AppLovin Reports Strong Earnings. The Stock Is Up. -- Barrons.com

2025-11-05 22:51; UTC

Uždarbis

DBS 3Q Total Income S$5.93B, Up 3% on Year >D05.SG

2025-11-05 22:50; UTC

Uždarbis

DBS 3Q Net S$2.95B, Down 2.0% on Year >D05.SG

2025-11-05 22:44; UTC

Įsigijimai, susijungimai, perėmimai

Pfizer Preps Improved Offer in Metsera Bidding War -- Update

2025-11-05 22:43; UTC

Rinkos pokalbiai

Uždarbis

NAB's Flat Dividend Disappoints Bears at Jarden -- Market Talk

2025-11-05 22:36; UTC

Rinkos pokalbiai

Global Forex and Fixed Income Roundup: Market Talk

2025-11-05 22:36; UTC

Rinkos pokalbiai

Macklem Warns Structural Adjustment Means Slow Canadian Growth -- Market Talk

2025-11-05 22:20; UTC

Rinkos pokalbiai

Bank of Canada Says Budget Plan Identifies Economy's Biggest Weakness -- Market Talk

2025-11-05 22:12; UTC

Įsigijimai, susijungimai, perėmimai

Pfizer: Will Take Action to Preserve Rights Under Previously-Signed Agreement >PFE

2025-11-05 22:11; UTC

Įsigijimai, susijungimai, perėmimai

Pfizer: Confident in Merits of Claims, Belief Metsera Has Acted in Breach of Contractual Obligations >PFE

2025-11-05 22:11; UTC

Įsigijimai, susijungimai, perėmimai

Pfizer Responds to Delaware Chancery Court Ruling

2025-11-05 22:01; UTC

Uždarbis

Great-West Lifeco 3Q Net C$1.16B >GWO.T

2025-11-05 22:01; UTC

Uždarbis

Great-West Lifeco 3Q Adj EPS C$1.33 >GWO.T

Akcijų palyginimas

Kainos pokytis

Celldex Therapeutics Inc Prognozė

Kainos tikslas

By TipRanks

106.29% į viršų

12 mėnesių prognozė

Vidutinis 49.2 USD 106.29%

Aukščiausias 67 USD

Žemiausias 25 USD

Remiantis 12 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Celldex Therapeutics Inc kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Stiprus pirkimas

12 ratings

Pirkti

Laikyti

Parduoti

Remiantis 12 analitikų, pateikusių Celldex Therapeutics Inc akcijų reitingus – Dist per pastaruosius 3 mėnesius.

Techninis įvertinimas

By Trading Central

18.91 / 20.63Palaikymas ir pasipriešinimas

Recent bullish events outweigh bearish events.

All events are bearish.

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

Apie bendrovę Celldex Therapeutics Inc

Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory, allergic, autoimmune, and other devastating diseases. The company's clinical development programs CDX-0159, a Phase II monoclonal antibody that binds the receptor tyrosine kinase KIT and inhibits its activity. It has research collaboration and license agreements with Yale University. The company was incorporated in 1983 and is headquartered in Hampton, New Jersey.